載入...
Refractory hypotension due to Nivolumab-induced adrenal insufficiency
Nivolumab, a new immune checkpoint inhibitor that has been found to improve outcomes for patients with some advanced cancers, is being increasingly used. Immune checkpoint inhibitors can cause immune-related adverse events, including dermatitis, enterocolitis, hepatitis and hypophysitis, but adrenal...
Na minha lista:
| 發表在: | Nagoya J Med Sci |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nagoya University
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5995729/ https://ncbi.nlm.nih.gov/pubmed/29915446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18999/nagjms.80.2.285 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|